GOLD; Daniel P.
Patent Applications and Registrations
Patent applications and USPTO patent grants for GOLD; Daniel P..The latest application filed is for "combination therapy".
- GOLD; Daniel P. - San Diego CA
- GOLD; Daniel P. - Del Mar CA
| Patent | Date |
|---|---|
| Combination Therapy App 20220265673 - GOLD; Daniel P. | 2022-08-25 |
| Combination Therapy App 20220193086 - GOLD; Daniel P. | 2022-06-23 |
| Combination therapy Grant 11,351,176 - Gold June 7, 2 | 2022-06-07 |
| Combination therapy Grant 11,304,953 - Gold April 19, 2 | 2022-04-19 |
| Treatment Of B Cell Malignancies App 20210299134 - GOLD; Daniel P. | 2021-09-30 |
| Combination Therapies App 20210267936 - GOLD; Daniel P. ; et al. | 2021-09-02 |
| Treatment Of Relapsed Follicular Lymphoma App 20210196725 - GOLD; Daniel P. | 2021-07-01 |
| Combination Therapy App 20210161909 - GOLD; Daniel P. | 2021-06-03 |
| Combination therapies Grant 10,980,774 - Gold , et al. April 20, 2 | 2021-04-20 |
| Combination Therapies App 20210100775 - GOLD; Daniel P. ; et al. | 2021-04-08 |
| Combination Therapy App 20210000838 - GOLD; Daniel P. | 2021-01-07 |
| Combination Therapy App 20200222415 - GOLD; Daniel P. | 2020-07-16 |
| Combination Therapy App 20200197403 - GOLD; Daniel P. | 2020-06-25 |
| Combination Therapy App 20190201409 - GOLD; Daniel P. | 2019-07-04 |
| Combination Therapies App 20180015067 - GOLD; Daniel P. ; et al. | 2018-01-18 |
| Altering A B Cell Pathology Using Self-derived Antigens In Conjunction With Specific-binding Cytoreductive Agent App 20160082113 - Gold; Daniel P. | 2016-03-24 |
| Combination Therapies App 20150258068 - Gold; Daniel P. ; et al. | 2015-09-17 |
| Method And Composition For Altering A B Cell Mediated Pathology App 20140322160 - Gold; Daniel P. ; et al. | 2014-10-30 |
| Method and composition for altering a B cell mediated pathology Grant 8,637,638 - Gold , et al. January 28, 2 | 2014-01-28 |
| Remission Therapy Of Cancer With Isoflavonoids App 20120251630 - Alvero; Ayesha B. ; et al. | 2012-10-04 |
| Method And Composition For Altering A B Cell Mediated Pathology App 20120114593 - Gold; Daniel P. ; et al. | 2012-05-10 |
| Method and composition for altering a B cell mediated pathology Grant 8,133,486 - Gold , et al. March 13, 2 | 2012-03-13 |
| Method and composition for altering a B cell mediated pathology Grant 8,114,404 - Gold , et al. February 14, 2 | 2012-02-14 |
| Method and composition for altering a B cell mediated pathology App 20050238645 - Gold, Daniel P. ; et al. | 2005-10-27 |
| Method and composition for altering a B cell mediated pathology App 20050202004 - Gold, Daniel P. ; et al. | 2005-09-15 |
| Method and composition for altering a B cell mediated pathology Grant 6,911,204 - Gold , et al. June 28, 2 | 2005-06-28 |
| Altering A B cell pathology using self-derived antigens in conjunction with specific-binding cytoreductive agent App 20050084495 - Gold, Daniel P. | 2005-04-21 |
| Method and composition for altering a B cell mediated pathology App 20030082178 - Gold, Daniel P. ; et al. | 2003-05-01 |
| Method and composition for altering a T cell mediated pathology App 20030012782 - Gold, Daniel P. ; et al. | 2003-01-16 |
| Vaccination and methods against multiple sclerosis resulting from pathogenic responses by specific T cell populations Grant 6,464,978 - Brostoff , et al. October 15, 2 | 2002-10-15 |
| Genetically engineered tumor cell vaccines App 20020006413 - Sobol, Robert E. ; et al. | 2002-01-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 